Quarterly report pursuant to Section 13 or 15(d)
Cover
Document and Entity Information
Financial Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements of Comprehensive Income (Unaudited)
Consolidated Statements of Cash Flows (Unaudited)
Notes to Financial Statements
Basis of Presentation and Significant Accounting Policies
Income per Common Share
Investment in Saneron CCEL Therapeutics, Inc. ("Saneron")
Stockholder's Equity
License Agreements
Legal Proceedings
Share Repurchase Plan
Subsequent Events
Accounting Policies
Basis of Presentation and Significant Accounting Policies (Policies)
Notes Tables
Basis of Presentation and Significant Accounting Policies (Tables)
Income per Common Share (Tables)
Stockholder's Equity (Tables)
License Agreements (Tables)
Notes Details
Basis of Presentation and Significant Accounting Policies - Additional Information (Detail)
Basis of Presentation and Significant Accounting Policies - Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail)
Income per Common Share - Calculation of Basic and Diluted Net Income Per Common Share (Detail)
Income per Common Share - Additional Information (Detail)
Investment in Saneron CCEL Therapeutics, Inc. ("Saneron") - Additional Information (Detail)
Stockholder's Equity - Additional Information (Detail)
Stockholder's Equity - Stock Option Activity for Options (Detail)
Stockholder's Equity - Significant Option Groups Outstanding and Exercisable Option and its Price and Contractual Life (Detail)
Stockholder's Equity - Summary of Non-Vested Options (Detail)
License Agreements - Additional Information (Detail)
License Agreements - Summary of License Fees Earned (Detail)
Legal Proceedings - Additional Information (Detail)
Share Repurchase Plan - Additional Information (Detail)
Subsequent Events - Additional Information (Detail)
Investment in Saneron CCEL Therapeutics, Inc. ("Saneron") - Additional Information (Detail)